These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23841283)

  • 1. [Aristolochic acid nephropathy: an issue worth more attention].
    Liu XH; Yang X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):554-8. PubMed ID: 23841283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.
    Jadot I; Declèves AE; Nortier J; Caron N
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs.
    Hong YT; Fu LS; Chung LH; Hung SC; Huang YT; Chi CS
    Pediatr Nephrol; 2006 Apr; 21(4):577-9. PubMed ID: 16520953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephropathy caused by Chinese plants and aristolochic acids: from clinical observation to experimental model].
    Debelle F; Nortier J
    Bull Mem Acad R Med Belg; 2006; 161(5):327-33. PubMed ID: 17283906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?
    Pozdzik AA; Berton A; Schmeiser HH; Missoum W; Decaestecker C; Salmon IJ; Vanherweghem JL; Nortier JL
    Histopathology; 2010 Mar; 56(4):449-63. PubMed ID: 20459552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad7 protects against chronic aristolochic acid nephropathy in mice.
    Dai XY; Zhou L; Huang XR; Fu P; Lan HY
    Oncotarget; 2015 May; 6(14):11930-44. PubMed ID: 25883225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aristolochic acid nephropathy: a worldwide problem.
    Debelle FD; Vanherweghem JL; Nortier JL
    Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological spectrums of aristolochic acid nephropathy.
    Chen D; Tang Z; Luo C; Chen H; Liu Z
    Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy.
    de Jonge H; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jan; 23(1):39-41. PubMed ID: 17913731
    [No Abstract]   [Full Text] [Related]  

  • 12. Aristolochic acid nephropathy: what we know and what we have to do.
    Li X; Wang H
    Nephrology (Carlton); 2004 Jun; 9(3):109-11. PubMed ID: 15189168
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephropathy associated with use of a Chinese herbal product containing aristolochic acid.
    Chau W; Ross R; Li JY; Yong TY; Klebe S; Barbara JA
    Med J Aust; 2011 Apr; 194(7):367-8. PubMed ID: 21470089
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure].
    Fujimura T; Tamaki K; Iida S; Tanaka H; Ikedou H; Takamiya Y; Kato S; Tanaka A; Okuda S
    Nihon Jinzo Gakkai Shi; 2005; 47(4):474-80. PubMed ID: 15971892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy.
    Chen B; Bai Y; Sun M; Ni X; Yang Y; Yang Y; Zheng S; Xu F; Dai S
    Int Urol Nephrol; 2012 Feb; 44(1):301-7. PubMed ID: 22116675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of aristolochic acid nephropathy in Korea.
    Ban TH; Min JW; Seo C; Kim DR; Lee YH; Chung BH; Jeong KH; Lee JW; Kim BS; Lee SH; Choi BS; Han JS; Yang CW
    Korean J Intern Med; 2018 Sep; 33(5):961-969. PubMed ID: 29551056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
    Luciano RL; Perazella MA
    Drug Saf; 2015 Jan; 38(1):55-64. PubMed ID: 25446374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model.
    Zeng Y; Li S; Wu J; Chen W; Sun H; Peng W; Yu X; Yang X
    Apoptosis; 2014 Aug; 19(8):1215-24. PubMed ID: 24841932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.